Imbiba, a UK-based specialist growth capital investor in leisure, education, and healthcare, has completed a strategic growth capital investment in Pindrop Hearing, a private clinical audiology business founded by Dr Rony Ganguly.
Since opening its flagship Harley Street clinic in 2017, Pindrop Hearing has established itself as a centre of clinical excellence, combining evidence-based audiology with exceptional patient care. It now operates three premium locations at Harley Street, Chelsea and Winchmore Hill, delivering advanced diagnostics, vestibular services and hearing aid provision across all major manufacturers.
“Pindrop represents a truly premium clinical platform in a structurally growing market,” said Heidi Duckworth, partner at Imbiba. “We believe there is a significant opportunity to roll out this model into other locations, delivering unbiased, customer-centric audiology services of the highest quality.”
The partnership marks the next stage in Pindrop’s evolution from a highly regarded clinical practice to a scalable premium audiology business.
Imbiba’s investment, one of its first pure play healthcare deals, will support and accelerate the roll-out of Pindrop Hearing, targeting 15 sites over the next 3-5 years across London and the South of England.
The growth capital investment of £2.5m values Pindrop at around £5m. Imbiba sees the opportunity to scale and exit at £30-40m EV in 4-5 years.
